These trials completed more than 12 months ago and should have reported results. Some have, some have not.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Ongoing, reported early 2004-000288-89 A 24 week, double blind, randomized study to investigate the effect of 500 µg Roflumilast tablets once daily versus placebo on parameters indicative of hyperinflation in patients with chronic obstruct... not-yet-due
Completed, but no date, and reported results 2004-000492-33 Healing of patients suffering from gastroesophageal reflux esophagitis grade C-D according to Los Angeles classification after treatment with pantoprazole-magnesium dihydrate 80 mg o.d. in comparison ... bad-data
Ongoing, reported early 2004-000493-32 Healing of patients suffering from gastroesophageal reflux esophagitis grade A-D according to Los Angeles classification after treatment with pantoprazole-magnesium dihydrate 80 mg o.d. in comparison ... not-yet-due
Completed, but no date, and reported results 2004-000825-31 Comparison of ciclesonide (80 µg or 160 µg once daily in the evening) and fluticasone propionate (100 µg twice daily in the morning and evening) in pediatric asthma patients bad-data
Ongoing, reported early 2004-001065-18 Morning versus evening administration of 500µg Roflumilast once dailyfor 6 weeks in patients with asthma. not-yet-due
Reported results 2004-001072-39 Comparison of Ciclesonide (80 µg Once Daily in the Evening) and Fluticasone propionate (100 µg Twice Daily) in Patients with Mild to Moderate Asthma 2006-01-09 due-trials
Reported results 2004-001681-40 Comparison of inhaled ciclesonide (640 µg/day) and fluticasone propionate (1000 µg/day) in patients with moderate and severe per-sistent asthma 2005-11-30 due-trials
Ongoing, reported early 2004-001838-16 Efficacy and safety of a fixed combination of ciclesonide and formoterol once or twice daily in the treatment of persistent asthma A randomized, double-blind, placebo-controlled, parallel-group, multi... not-yet-due
Reported results 2004-002983-80 Comparison of the Efficacy of a Fixed Combination of Ciclesonide and Formoterol versus a Fixed Combination of Fluticasone and Salmeterol 2005-08-02 due-trials
Listed as ongoing, but also has a completion date 2004-004442-40 500µg roflumilast once daily in combination with 50µg salmeterol twice daily versus 50µg salmeterol twice daily alone over 52 weeks in patients with COPD. 2005-06-15 bad-data
Listed as ongoing, but also has a completion date and reported results 2004-004708-19 A dose range finding study of formoterol administered once daily in the evening in combination with ciclesonide using the UltrahalerTM versus monotherapy of each drug in asthmatic patients 2006-01-26 bad-data
Listed as ongoing, but also has a completion date and reported results 2004-004806-25 Evaluation of the complete remission rates in patients with symptomatic non-erosive reflux disease (NERD) or erosive gastroesophageal reflux disease (GERD) treated with pantoprazole 40 mg o.d. over 4... 2006-03-21 bad-data
Ongoing, reported early 2005-000711-10 Determination of the performance characteristics of ReQuestTM in Practice in the stepped down management of GORD not-yet-due
Listed as ongoing, but also has a completion date and reported results 2005-001242-17 Efficacy and Safety – Study by ALTANA on Ciclesonide in Pre-school Asthma Patients 2007-05-31 bad-data
Reported results 2005-001386-34 Effect of Ciclesonide (320 µg/day) vs. Fluticasone Propionate (375 µg/day) vs. Placebo on Short-term Linear Growth Rate and HPA-axis Function in Prepubertal Children with Mild Asthma 2006-06-21 due-trials
Reported results 2005-001497-27 Effect of pantoprazole on sleep-related breathing disorders 2007-01-24 due-trials
Not reported 2005-001740-24 A Dose Range Finding Study of Formoterol Fumarate administered twice daily using the Ultrahaler™ in Patients with Asthma 2006-02-03 due-trials
Reported results 2005-002163-84 Comparison of the Efficacy and Safety of 160 µg Ciclesonide Administered Once Daily in the Evening with or without Different Spacer Types in Patients with Asthma 2006-05-10 due-trials
Listed as ongoing, but also has a completion date and reported results 2005-003485-42 Treatment response in patients with symptoms due to gastroesophageal reflux disease either with or without esophagitis treated with pantoprazole sodium 40 mg o.d. over 8 weeks 2007-08-14 bad-data
Listed as ongoing, but also has a completion date and reported results 2005-003937-42 Effect of roflumilast on exacerbation rate in patients with COPD 2008-09-25 bad-data
Listed as ongoing, but also has a completion date and reported results 2005-003938-18 Effect of roflumilast on exacerbation rate in patients with COPD. A 52 weeks, double-blind study with 500 mcg roflumilast once daily versus placebo 2008-08-14 bad-data
Reported results 2005-004856-11 Symptom reduction in hospitalized patients suffering from symptomatic non-erosive or erosive gastroesophageal reflux disease treated with pantoprazole 20 or 40 mg o.d. for 7 days 2007-06-29 due-trials
Listed as ongoing, but also has a completion date and reported results 2005-005080-28 Effect of roflumilast in COPD patients treated with salmeterol. A 24 week, double-blind study with 500 g roflumilast once daily versus placebo . Final protocol v.8.0 31 January 2006 2008-02-12 bad-data
Listed as ongoing, but also has a completion date and reported results 2006-000803-40 A comparative study of inhaled ciclesonide versus placebo in children with asthma (RAINBOW) 2007-11-29 bad-data
Reported results 2006-000926-30 Investigation of clinical endpoints for treatment-induced gastroesophageal reflux disease (GERD) symptom changes 2007-03-29 due-trials
Reported results 2006-002214-35 Free, not protein-bound concentrations of budesonide in subcutaneous adipose tissue, muscle tissue, and serum after oral inhalation via Turbohaler® 2006-08-16 due-trials
Not reported 2006-002777-42 Endoscopic healing and tolerability of Soraprazan 20 mg qd compared to Soraprazan 10 mg qd and to Esomeprazole 40 mg qd in patients suffering from GERD Grade A-D (LA classification) 2007-01-31 due-trials
Not reported 2006-002779-42 Symptom relief and tolerability of Soraprazan 20 mg qd and Soraprazan 10 mg qd compared to Esomeprazole 20 mg qd in patients with non-erosive gastroesophageal reflux disease (NERD) 2007-01-31 due-trials
Listed as ongoing, but also has a completion date and reported results 2006-004508-37 Effect of roflumilast in COPD patients treated with tiotropium. A 24-week, double-blind study with 500 g roflumilast once daily versus placebo. 2008-07-07 bad-data
Ongoing, reported early 2006-004882-32 Evaluation of clinical endpoints for treatment-induced changes in GERD-related symptoms not-yet-due